|
MED4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.252380E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.669800E-01 |
| Normal-vs-Stage2 |
3.509400E-01 |
| Normal-vs-Stage3 |
1.022350E-04 |
| Normal-vs-Stage4 |
9.89780000000273E-05 |
| Stage1-vs-Stage2 |
7.799200E-01 |
| Stage1-vs-Stage3 |
7.83760000000466E-05 |
| Stage1-vs-Stage4 |
2.234700E-04 |
| Stage2-vs-Stage3 |
6.063500E-02 |
| Stage2-vs-Stage4 |
5.116400E-02 |
| Stage3-vs-Stage4 |
8.759000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.698700E-03 |
| Normal-vs-AfricanAmerican |
8.067400E-01 |
| Normal-vs-Asian |
8.309000E-01 |
| Caucasian-vs-AfricanAmerican |
3.715300E-03 |
| Caucasian-vs-Asian |
4.113000E-01 |
| AfricanAmerican-vs-Asian |
7.640000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.713930E-02 |
| Normal-vs-Female |
2.092400E-02 |
| Male-vs-Female |
8.463400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.041000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.175900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.161500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.442070E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.071800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.129000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.084000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.706400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.307180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.640400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.226000E-02 |
| Normal-vs-Grade 2 |
5.204000E-01 |
| Normal-vs-Grade 3 |
4.198700E-04 |
| Normal-vs-Grade 4 |
6.83240000021179E-07 |
| Grade 1-vs-Grade 2 |
2.329800E-02 |
| Grade 1-vs-Grade 3 |
3.70160000000563E-05 |
| Grade 1-vs-Grade 4 |
5.37979999992722E-07 |
| Grade 2-vs-Grade 3 |
1.760360E-04 |
| Grade 2-vs-Grade 4 |
4.30100000059497E-08 |
| Grade 3-vs-Grade 4 |
3.957400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.582600E-01 |
| Normal-vs-ccB subtype |
1.81696999999037E-05 |
| ccA subtype-vs-ccB subtype |
6.78329947767509E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.224900E-03 |
| Normal-vs-N1 |
6.037500E-03 |
| N0-vs-N1 |
1.624760E-01 |
|
|
